Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction

Clicks: 188
ID: 111922
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
To examine the causes of congenital nasolacrimal duct obstruction (CNLDO) using dacryoendoscopy, and to evaluate the surgical outcomes of primary transcanalicular endoscopic dacryoplasty. The subjects of this study were a total of 56 eyes of 46 Japanese children aged one to five years old (mean, 29.1 ± 14.0 months old) with clinically diagnosed CNLDO. The blockage was visualized and probed using a dacryoendoscope (MD10 with a 20 G probe, Fiber Tech Co., Ltd., Japan) under general anesthesia. We used a self-retaining bicanalicular lacrimal stent (Lacrifast®, Kaneka Co., Ltd., Japan) for nasolacrimal duct intubation. In each case the obstruction was found to be caused by a single focal blockage at the distal end of the duct. A nasolacrimal dacryolith was observed in 5 eyes (9%) and successfully removed using the dacryoendoscope. The success rate of probing by subsequent nasolacrimal duct intubation was 100%. No complications were observed. We obtained a 100% success rate with primary transcanalicular endoscopic dacryoplasty for the treatment of CNLDO. Direct visualization inside the lacrimal passage allowed for precise probing, even in infants, leading to successful treatment of CNLDO without any complications.
Reference Key
matsumura2019eyetranscanalicular Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Nozomi Matsumura;Toru Suzuki;Satoshi Goto;Takeshi Fujita;Shin Yamane;Maiko Maruyama-Inoue;Kazuaki Kadonosono;Nozomi Matsumura;Toru Suzuki;Satoshi Goto;Takeshi Fujita;Shin Yamane;Maiko Maruyama-Inoue;Kazuaki Kadonosono;
Journal eye
Year 2019
DOI
doi:10.1038/s41433-019-0374-6
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.